Showing 1 - 6 results of 6 for search 'Sheng-Long Ye', query time: 0.04s
Refine Results
-
1
-
2
-
3
Evaluation of sorafenib in Chinese unresectable hepatocellular carcinoma patients with prior surgery and portal vein tumor thrombosis: A subset analysis of GIDEON study data by Sheng-Long Ye, Xiaoping Chen, Jiamei Yang, Ping Bie, Shuijun Zhang, Fengyong Liu, Luming Liu, Jie Zhou, Kefeng Dou, Christina SM Yip, Xiaolei Yang
Published 2017-03-01
Article -
4
A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements by Masatoshi Kudo, Kwang-Hyub Han, Sheng-Long Ye, Jian Zhou, Yi-Hsiang Huang, Shi-Ming Lin, Chung-Kwe Wang, Masafumi Ikeda, Stephen Lam Chan, Su Pin Choo, Shiro Miyayama, Ann Lii Cheng
Published 2020-05-01
Article -
5
Angiogenesis enhanced by treatment damage to hepatocellular carcinoma through the release of GDF15 by Gang Dong, Qiong‐Dan Zheng, Min Ma, Si‐Fan Wu, Rui Zhang, Rong‐Rong Yao, Yin‐Ying Dong, Hui Ma, Dong‐Mei Gao, Sheng‐Long Ye, Jie‐Feng Cui, Zheng‐Gang Ren, Rong‐Xin Chen
Published 2018-03-01
Article -
6
Safety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma: subgroup analysis of the GIDEON study by Sheng-Long Ye, Jiamei Yang, Ping Bie, Shuijun Zhang, Xiaoping Chen, Fengyong Liu, Luming Liu, Jie Zhou, Kefeng Dou, Chunyi Hao, Guoliang Shao, Qiang Xia, Yajin Chen, Jijin Yang, Xiaxing Deng, Yunpeng Liu, Yunfei Yuan, Zhiren Fu, Keiko Nakajima, Zhengguang Lv
Published 2018-03-01
Article